Koers Acura Pharmaceuticals, Inc. OTC Bulletin Board
Aandelen
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2020 | 3,57 mln. 3,32 mln. | Omzet 2021 | 1,56 mln. 1,45 mln. | Marktkapitalisatie | 32,54 mln. 30,28 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2020 | -1 mln. -930K | Nettowinst (verlies) 2021 | - 0 | EV/omzet 2020 | 2,91 x |
Nettoschuld 2020 | 5,86 mln. 5,45 mln. | Nettoschuld 2021 | 135K 126K | EV/omzet 2021 | 20,9 x |
K/w-verhouding 2020 |
-5,25
x | K/w-verhouding 2021 |
-25
x | Werknemers | - |
Dividendrendement 2020 * |
-
| Dividendrendement 2021 |
-
| Vrij verhandelbaar | 15,27% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Robert Jones
CEO | Chief Executive Officer | 65 | 07-04-08 |
Peter Clemens
DFI | Director of Finance/CFO | 71 | 01-02-98 |
Bob Seiser
AUD | Comptroller/Controller/Auditor | 60 | 01-03-98 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Peter Clemens
DFI | Director of Finance/CFO | 71 | 01-02-98 |
Bruce Wesson
BRD | Director/Board Member | 81 | 01-03-98 |
William Skelly
BRD | Director/Board Member | 73 | 01-05-96 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+2,93% | 106 mld. | |
+7,02% | 23,47 mld. | |
-14,60% | 21,9 mld. | |
-7,05% | 18,77 mld. | |
-38,55% | 17,85 mld. | |
-8,83% | 16,78 mld. | |
+5,51% | 14,41 mld. | |
+37,49% | 12,86 mld. | |
+329,39% | 8,78 mld. |
- Beurs
- Aandelen
- Koers ACUR
- Koers